SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,292,000 | +1232.0% | 11,294 | +884.7% | 0.01% | +800.0% |
| Q3 2019 | $97,000 | +24.4% | 1,147 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $78,000 | -25.7% | 1,129 | -21.8% | 0.00% | 0.0% |
| Q1 2019 | $105,000 | +36.4% | 1,444 | +7.0% | 0.00% | 0.0% |
| Q4 2018 | $77,000 | -11.5% | 1,349 | +20.8% | 0.00% | 0.0% |
| Q3 2018 | $87,000 | +569.2% | 1,117 | +464.1% | 0.00% | – |
| Q2 2018 | $13,000 | +44.4% | 198 | +11.2% | 0.00% | – |
| Q1 2018 | $9,000 | -65.4% | 178 | -64.0% | 0.00% | – |
| Q4 2017 | $26,000 | -62.3% | 495 | -60.7% | 0.00% | -100.0% |
| Q3 2017 | $69,000 | +109.1% | 1,261 | +95.8% | 0.00% | 0.0% |
| Q2 2017 | $33,000 | -17.5% | 644 | +3.0% | 0.00% | 0.0% |
| Q1 2017 | $40,000 | +110.5% | 625 | +74.6% | 0.00% | – |
| Q4 2016 | $19,000 | +11.8% | 358 | +11.5% | 0.00% | – |
| Q3 2016 | $17,000 | +6.2% | 321 | -22.1% | 0.00% | – |
| Q2 2016 | $16,000 | – | 412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |